Precancerous  ||| S:0 E:13 ||| JJ
conditions  ||| S:13 E:24 ||| NNS
and  ||| S:24 E:28 ||| CC
lesions  ||| S:28 E:36 ||| NNS
of  ||| S:36 E:39 ||| IN
the  ||| S:39 E:43 ||| DT
stomach  ||| S:43 E:51 ||| JJ
Gastric  ||| S:51 E:59 ||| JJ
carcinoma  ||| S:59 E:69 ||| NN
is  ||| S:69 E:72 ||| VBZ
a  ||| S:72 E:74 ||| DT
common  ||| S:74 E:81 ||| JJ
malignant  ||| S:81 E:91 ||| JJ
disease  ||| S:91 E:99 ||| NN
associated  ||| S:99 E:110 ||| VBN
with  ||| S:110 E:115 ||| IN
an  ||| S:115 E:118 ||| DT
unfavorable  ||| S:118 E:130 ||| JJ
prognosis  ||| S:130 E:140 ||| NN
in  ||| S:140 E:143 ||| IN
the  ||| S:143 E:147 ||| DT
case  ||| S:147 E:152 ||| NN
of  ||| S:152 E:155 ||| IN
late  ||| S:155 E:160 ||| JJ
dia-gnosis ||| S:160 E:170 ||| NN
.  ||| S:170 E:172 ||| .
The  ||| S:172 E:176 ||| DT
most  ||| S:176 E:181 ||| RBS
significant  ||| S:181 E:193 ||| JJ
precancerous  ||| S:193 E:206 ||| JJ
condition  ||| S:206 E:216 ||| NN
is  ||| S:216 E:219 ||| VBZ
chronic  ||| S:219 E:227 ||| JJ
atrophic  ||| S:227 E:236 ||| JJ
gastritis  ||| S:236 E:246 ||| NN
and  ||| S:246 E:250 ||| CC
intestinal  ||| S:250 E:261 ||| NNS
metaplasia  ||| S:261 E:272 ||| VBP
caused  ||| S:272 E:279 ||| VBN
by  ||| S:279 E:282 ||| IN
Helicobacter  ||| S:282 E:295 ||| NNP
pylori  ||| S:295 E:302 ||| JJ
infection ||| S:302 E:311 ||| NN
.  ||| S:311 E:313 ||| .
These  ||| S:313 E:319 ||| DT
longlasting  ||| S:319 E:331 ||| JJ
changes  ||| S:331 E:339 ||| NNS
may  ||| S:339 E:343 ||| MD
lead  ||| S:343 E:348 ||| VB
to  ||| S:348 E:351 ||| TO
formation  ||| S:351 E:361 ||| NN
of  ||| S:361 E:364 ||| IN
dysplastic  ||| S:364 E:375 ||| JJ
precancerous  ||| S:375 E:388 ||| JJ
lesions ||| S:388 E:395 ||| NNS
.  ||| S:395 E:397 ||| .
Upper  ||| S:397 E:403 ||| JJ
endoscopy  ||| S:403 E:413 ||| NN
and  ||| S:413 E:417 ||| CC
histologic  ||| S:417 E:428 ||| JJ
examination  ||| S:428 E:440 ||| NN
of  ||| S:440 E:443 ||| IN
forceps  ||| S:443 E:451 ||| JJ
bio-psy  ||| S:451 E:459 ||| JJ
specimens  ||| S:459 E:469 ||| NNS
play  ||| S:469 E:474 ||| VBP
a  ||| S:474 E:476 ||| DT
key  ||| S:476 E:480 ||| JJ
role  ||| S:480 E:485 ||| NN
in  ||| S:485 E:488 ||| IN
the  ||| S:488 E:492 ||| DT
dia-gnosis  ||| S:492 E:503 ||| JJ
of  ||| S:503 E:506 ||| IN
gastric  ||| S:506 E:514 ||| JJ
precancerous  ||| S:514 E:527 ||| JJ
conditions  ||| S:527 E:538 ||| NNS
and  ||| S:538 E:542 ||| CC
lesions ||| S:542 E:549 ||| NNS
.  ||| S:549 E:551 ||| .
Helicobacter  ||| S:551 E:564 ||| JJ
pylori  ||| S:564 E:571 ||| JJ
eradication  ||| S:571 E:583 ||| JJ
therapy  ||| S:583 E:591 ||| NN
and  ||| S:591 E:595 ||| CC
endoscopic  ||| S:595 E:606 ||| JJ
surveillance  ||| S:606 E:619 ||| NNS
are  ||| S:619 E:623 ||| VBP
main  ||| S:623 E:628 ||| JJ
therapeutic  ||| S:628 E:640 ||| JJ
modalities  ||| S:640 E:651 ||| NN
of  ||| S:651 E:654 ||| IN
gastric  ||| S:654 E:662 ||| JJ
precancerous  ||| S:662 E:675 ||| JJ
conditions ||| S:675 E:685 ||| NNS
.  ||| S:685 E:687 ||| .
Localized  ||| S:687 E:697 ||| JJ
precancerous  ||| S:697 E:710 ||| JJ
lesions  ||| S:710 E:718 ||| NNS
and  ||| S:718 E:722 ||| CC
early  ||| S:722 E:728 ||| JJ
gastric  ||| S:728 E:736 ||| JJ
neoplasia  ||| S:736 E:746 ||| NN
without  ||| S:746 E:754 ||| IN
the  ||| S:754 E:758 ||| DT
risk  ||| S:758 E:763 ||| NN
of  ||| S:763 E:766 ||| IN
lymphatic  ||| S:766 E:776 ||| JJ
spread  ||| S:776 E:783 ||| NN
could  ||| S:783 E:789 ||| MD
be  ||| S:789 E:792 ||| VB
cured  ||| S:792 E:798 ||| VBN
by  ||| S:798 E:801 ||| IN
means  ||| S:801 E:807 ||| NNS
of  ||| S:807 E:810 ||| IN
endoscopic  ||| S:810 E:821 ||| JJ
resection  ||| S:821 E:831 ||| JJ
techniques ||| S:831 E:841 ||| NNS
.  ||| S:841 E:843 ||| .
